Plant species composition on two rock outcrops from the northern Western Ghats, Maharashtra, India

The Western Ghats are full of high altitude plateaus/rock outcrops amidst mesic forests. Throughout the world, rock outcrops are isolated habitats and known for their uniqueness with respect to environmental variables and biodiversity and well known as centers of species endemism. In India such special habitats are geographically known but very less information is available about their floristic wealth. Available studies are occasional and limited to ecology. Due to a lack of appropriate information and errors in the study models of random sampling, important habitats may get misinterpreted and pose a threat to conservation. A comprehensive botanical study of two rock outcrops, Durgawadi Plateau (DP) and Naneghat Plateau (NP), on the escarpment of the northern Western Ghats revealed a very high within-site (360 taxa on DP and 249 taxa on NP) and between-site plant diversity totaling to 443 taxa of specific and infraspecific ranks. The individual outcrop areas are very small (2.8793km2 and 0.7524km2 respectively for DP and NP) but harbor a huge diversity of flowering plants. The commonly shared taxa are relatively low (37% of the taxa recorded) indicating that the two outcrops are floristically very distinct from each other. They are also distinct in terms of soil composition, though on the same crest line of Sahyadri and quite close to each other. The study emphasizes the need for micro-level inventories of smaller areas by taking intensive surveys for documentation of different aspects of the abiotic and biotic diversity as well as other environmental and anthropogenic variables

The BioKET Biodiversity Data Warehouse: Data and Knowledge Integration and Extraction

International audienceBiodiversity datasets are generally stored in different for-mats. This makes it difficult for biologists to combine and integrate them to retrieve useful information for the purpose of, for example, efficiently classify specimens. In this paper, we present BioKET, a data warehouse which is a consolidation of heterogeneous data sources stored in different formats. For the time being, the scopus of BioKET is botanical. We had, among others things, to list all the existing botanical ontologies and re-late terms in BioKET with terms in these ontologies. We demonstrate the usefulness of such a resource by applying FIST, a combined biclus-tering and conceptual association rule extraction method on a dataset extracted from BioKET to analyze the risk status of plants endemic to Laos. Besides, BioKET may be interfaced with other resources, like GeoCAT, to provide a powerful analysis tool for biodiversity data

Global Impact of COVID-19 on Stroke Care and IV Thrombolysis

OBJECTIVE: To measure the global impact of COVID-19 pandemic on volumes of IV thrombolysis (IVT), IVT transfers, and stroke hospitalizations over 4 months at the height of the pandemic (March 1 to June 30, 2020) compared with 2 control 4-month periods. METHODS: We conducted a cross-sectional, observational, retrospective study across 6 continents, 70 countries, and 457 stroke centers. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. RESULTS: There were 91,373 stroke admissions in the 4 months immediately before compared to 80,894 admissions during the pandemic months, representing an 11.5% (95% confidence interval [CI] -11.7 to -11.3, p < 0.0001) decline. There were 13,334 IVT therapies in the 4 months preceding compared to 11,570 procedures during the pandemic, representing a 13.2% (95% CI -13.8 to -12.7, p < 0.0001) drop. Interfacility IVT transfers decreased from 1,337 to 1,178, or an 11.9% decrease (95% CI -13.7 to -10.3, p = 0.001). Recovery of stroke hospitalization volume (9.5%, 95% CI 9.2-9.8, p < 0.0001) was noted over the 2 later (May, June) vs the 2 earlier (March, April) pandemic months. There was a 1.48% stroke rate across 119,967 COVID-19 hospitalizations. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was noted in 3.3% (1,722/52,026) of all stroke admissions. CONCLUSIONS: The COVID-19 pandemic was associated with a global decline in the volume of stroke hospitalizations, IVT, and interfacility IVT transfers. Primary stroke centers and centers with higher COVID-19 inpatient volumes experienced steeper declines. Recovery of stroke hospitalization was noted in the later pandemic months. © 2021 American Academy of Neurology

Global Impact of the COVID-19 Pandemic on Stroke Volumes and Cerebrovascular Events: One-Year Follow-up.

Declines in stroke admission, intravenous thrombolysis, and mechanical thrombectomy volumes were reported during the first wave of the COVID-19 pandemic. There is a paucity of data on the longer-term effect of the pandemic on stroke volumes over the course of a year and through the second wave of the pandemic. We sought to measure the impact of the COVID-19 pandemic on the volumes of stroke admissions, intracranial hemorrhage (ICH), intravenous thrombolysis (IVT), and mechanical thrombectomy over a one-year period at the onset of the pandemic (March 1, 2020, to February 28, 2021) compared with the immediately preceding year (March 1, 2019, to February 29, 2020). We conducted a longitudinal retrospective study across 6 continents, 56 countries, and 275 stroke centers. We collected volume data for COVID-19 admissions and 4 stroke metrics: ischemic stroke admissions, ICH admissions, intravenous thrombolysis treatments, and mechanical thrombectomy procedures. Diagnoses were identified by their ICD-10 codes or classifications in stroke databases. There were 148,895 stroke admissions in the one-year immediately before compared to 138,453 admissions during the one-year pandemic, representing a 7% decline (95% confidence interval [95% CI 7.1, 6.9]; p<0.0001). ICH volumes declined from 29,585 to 28,156 (4.8%, [5.1, 4.6]; p<0.0001) and IVT volume from 24,584 to 23,077 (6.1%, [6.4, 5.8]; p<0.0001). Larger declines were observed at high volume compared to low volume centers (all p<0.0001). There was no significant change in mechanical thrombectomy volumes (0.7%, [0.6,0.9]; p=0.49). Stroke was diagnosed in 1.3% [1.31,1.38] of 406,792 COVID-19 hospitalizations. SARS-CoV-2 infection was present in 2.9% ([2.82,2.97], 5,656/195,539) of all stroke hospitalizations. There was a global decline and shift to lower volume centers of stroke admission volumes, ICH volumes, and IVT volumes during the 1st year of the COVID-19 pandemic compared to the prior year. Mechanical thrombectomy volumes were preserved. These results suggest preservation in the stroke care of higher severity of disease through the first pandemic year. This study is registered under NCT04934020